Table 2.
Bioactions of SPMs on ion transport and mucus secretion, demonstrated in non-CF models.
| Ion transport and hydration | ||||
|---|---|---|---|---|
| Conditions | SPMs | Models | Bioactions | References |
| In vitro studies | ||||
| Other | LXA4 | Human bronchial epithelial cells (primary and 16HBE14o-) | Stimulates Ca2+ -dependent Cl- secretion | Bonnans et al., 2003 |
| Acute lung injury | LXA4 | Rat primary alveolar type II cells | Stimulates expression of CFTR | Yang et al., 2013 |
| Mar1 | Stimulates expression of ENaC α, β and Na-K-ATPase α1, β1 | Zhang et al., 2017 | ||
| In vivo studies | ||||
| Acute lung injury | LXA4 | Sprague-Dawley rat | Stimulate airway fluid clearance | Yang et al., 2013 |
| RvD1 | Wang Q. et al., 2014 | |||
| Mar1 | Zhang et al., 2017 | |||
| Mucus secretion | ||||
| Conditions | SPMs | Models | Bioactions | References |
| In vitro studies | ||||
| Other | LXA4 | Sprague-Dawley Rat primary conjunctival goblet cells | Increases glycoconjugate secretion | Hodges et al., 2017 |
| RvD1 | Lippestad et al., 2017 | |||
| RvD2 | Botten et al., 2019 | |||
| RvE1 | Lippestad et al., 2017 | |||
| Mar1 | Increases glycoconjugate secretion Counter-regulates histamine-induced secretion |
Olsen et al., 2020 | ||
| RvD1 & RvE1 | Sprague-Dawley Rat and Human primary conjunctival goblet cells | Inhibits leukotriene-induced glycoconjugate secretion | Dartt et al., 2011 | |
| RvD1 & AT-RvD1 | Counter-regulates histamine-induced secretion | Li et al., 2013 | ||
| In vivo studies | ||||
| Asthma | RvE1 | BALB/c mice | Lowers mucus score | Aoki et al., 2008 |